Trial · NCT06319170
Participant flow44
How many started, completed or left each group, period by period.
41 to 44 of 44
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 8-Week Follow-up Period | NOT COMPLETED | ZYPREXA | 0 | |
| 8-Week Follow-up Period | NOT COMPLETED | Cohort 1: Olanzapine (Fast-D) | 1 | |
| 8-Week Follow-up Period | NOT COMPLETED | Cohort 2: Olanzapine (To-be-marketed) | 2 | |
| 8-Week Follow-up Period | NOT COMPLETED | Cohort 3: Olanzapine (Slow-C) | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06319170/flow?page=3